These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Glucagon-Like Peptide 1 Increases β-Cell Regeneration by Promoting α- to β-Cell Transdifferentiation. Lee YS; Lee C; Choung JS; Jung HS; Jun HS Diabetes; 2018 Dec; 67(12):2601-2614. PubMed ID: 30257975 [TBL] [Abstract][Full Text] [Related]
6. β cell membrane remodelling and procoagulant events occur in inflammation-driven insulin impairment: a GLP-1 receptor dependent and independent control. Gleizes C; Kreutter G; Abbas M; Kassem M; Constantinescu AA; Boisramé-Helms J; Yver B; Toti F; Kessler L J Cell Mol Med; 2016 Feb; 20(2):231-42. PubMed ID: 26607759 [TBL] [Abstract][Full Text] [Related]
7. The glucagon-like peptide-1 analogue liraglutide promotes autophagy through the modulation of 5'-AMP-activated protein kinase in INS-1 β-cells under high glucose conditions. Miao X; Gu Z; Liu Y; Jin M; Lu Y; Gong Y; Li L; Li C Peptides; 2018 Feb; 100():127-139. PubMed ID: 28712893 [TBL] [Abstract][Full Text] [Related]
8. Liraglutide, a human glucagon-like peptide-1 analogue, stimulates AKT-dependent survival signalling and inhibits pancreatic β-cell apoptosis. Kapodistria K; Tsilibary EP; Kotsopoulou E; Moustardas P; Kitsiou P J Cell Mol Med; 2018 Jun; 22(6):2970-2980. PubMed ID: 29524296 [TBL] [Abstract][Full Text] [Related]
9. Long-term liraglutide treatment is associated with increased insulin content and secretion in β-cells, and a loss of α-cells in ZDF rats. Schwasinger-Schmidt T; Robbins DC; Williams SJ; Novikova L; Stehno-Bittel L Pharmacol Res; 2013 Oct; 76():58-66. PubMed ID: 23891763 [TBL] [Abstract][Full Text] [Related]
10. Human islets contain a subpopulation of glucagon-like peptide-1 secreting α cells that is increased in type 2 diabetes. Campbell SA; Golec DP; Hubert M; Johnson J; Salamon N; Barr A; MacDonald PE; Philippaert K; Light PE Mol Metab; 2020 Sep; 39():101014. PubMed ID: 32413586 [TBL] [Abstract][Full Text] [Related]
11. Processing of proglucagon to GLP-1 in pancreatic α-cells: is this a paracrine mechanism enabling GLP-1 to act on β-cells? Whalley NM; Pritchard LE; Smith DM; White A J Endocrinol; 2011 Oct; 211(1):99-106. PubMed ID: 21795304 [TBL] [Abstract][Full Text] [Related]
12. Signaling pathways implicated in the stimulation of beta-cell proliferation by extracellular matrix. Parnaud G; Hammar E; Ribaux P; Donath MY; Berney T; Halban PA Mol Endocrinol; 2009 Aug; 23(8):1264-71. PubMed ID: 19443607 [TBL] [Abstract][Full Text] [Related]
13. The human glucagon-like peptide-1 analogue liraglutide regulates pancreatic beta-cell proliferation and apoptosis via an AMPK/mTOR/P70S6K signaling pathway. Miao XY; Gu ZY; Liu P; Hu Y; Li L; Gong YP; Shu H; Liu Y; Li CL Peptides; 2013 Jan; 39():71-9. PubMed ID: 23116613 [TBL] [Abstract][Full Text] [Related]
14. Culture of adult human islet preparations with hepatocyte growth factor and 804G matrix is mitogenic for duct cells but not for beta-cells. Lefebvre VH; Otonkoski T; Ustinov J; Huotari MA; Pipeleers DG; Bouwens L Diabetes; 1998 Jan; 47(1):134-7. PubMed ID: 9421388 [TBL] [Abstract][Full Text] [Related]
15. Islet distribution of Peptide YY and its regulatory role in primary mouse islets and immortalised rodent and human beta-cell function and survival. Khan D; Vasu S; Moffett RC; Irwin N; Flatt PR Mol Cell Endocrinol; 2016 Nov; 436():102-13. PubMed ID: 27465830 [TBL] [Abstract][Full Text] [Related]
16. The Akt/FoxO1/p27 pathway mediates the proliferative action of liraglutide in β cells. Fang D; Huang Z; Guan H; Liu J; Yao B; Xiao H; Li Y Mol Med Rep; 2012 Jan; 5(1):233-8. PubMed ID: 21964769 [TBL] [Abstract][Full Text] [Related]